explore -WSS

explore

author：comprehensive 2025-08-04 03:41:52 - browse：818

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： AstraZeneca to buy developer of next

leisure time

WSS

SCOTUS questions limit to govt efforts to fight misinformation

Colonoscopy prep: Liquid

World's first CRISPR

Neuroscience’s long legacy of racism

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Colonoscopy prep: Liquid

explore

explore

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

What does generative AI mean for health care? We asked experts

Gain of function research would be limited under House proposal

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In key trial, Verve's treatment lowers cholesterol levels in patients

Tori Bowie and the unacceptable rates of Black maternal death

Congress must reauthorize a committee to support older Americans

Apple is now the first public company to be valued at $3 trillion

App could help diagnose ear infections more accurately — and at home

knowledge

David Sabatini, ex

A daunting task: navigating dual Medicare, Medicaid eligibility

Morphosys mixed study results for blood cancer drug

Physicians and social media: If you see something, say something?

5 to watch: Tech startups trying to solve health care's staffing crisis

Neuroscience’s long legacy of racism

leisure time

Wikipedia

leisure time

entertainment